Pfizer raises 2021 sales forecast for Covid vaccines to $26 bn

Focal brain lesion study shows cognitive impairment may be better predicted by looking at damage to white matter
4 May 2021
Researchers advance 3D printing to aid tissue replacement
4 May 2021

Pfizer raises 2021 sales forecast for Covid vaccines to $26 bn

Pfizer sharply increased its projections for 2021 revenues and profits on Tuesday, citing much higher Covid-19 vaccine sales as it targets the inoculations as a “durable” revenue stream.

Comments are closed.